Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann C Kroksveen

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Analytical Chemistry|February 21, 2009
Discriminating variable test and selectivity ratio plot: quantitative tools for interpretation and variable (biomarker) selection in complex spectral or chromatographic profilesTarja Rajalahti, Reidar Arneberg, Ann C Kroksveen, et al.
Biochimica Et Biophysica Acta|December 21, 2014
Cerebrospinal fluid proteomics in multiple sclerosisAnn C Kroksveen, Jill A Opsahl, Astrid Guldbrandsen, et al.
Journal of Proteome Research|May 27, 2010
A multivariate approach to reveal biomarker signatures for disease classification: application to mass spectral profiles of cerebrospinal fluid from patients with multiple sclerosisTarja Rajalahti, Ann C Kroksveen, Reidar Arneberg, et al.
Cerebrospinal Fluid Research|June 12, 2010
Arachnoid cysts do not contain cerebrospinal fluid: A comparative chemical analysis of arachnoid cyst fluid and cerebrospinal fluid in adultsMagnus Berle, Knut G Wester, Rune J Ulvik, et al.
Proteomics. Clinical Applications|December 8, 2010
Pre-analytical influence on the low molecular weight cerebrospinal fluid proteomeFrode S Berven, Ann C Kroksveen, Magnus Berle, et al.
Analytical Chemistry|August 23, 2007
Pretreatment of mass spectral profiles: application to proteomic dataReidar Arneberg, Tarja Rajalahti, Kristian Flikka, et al.
Fluids and Barriers of the CNS|May 24, 2011
Protein profiling reveals inter-individual protein homogeneity of arachnoid cyst fluid and high qualitative similarity to cerebrospinal fluidMagnus Berle, Ann C Kroksveen, Oystein A Haaland, et al.
Journal of Proteomics|October 13, 2012
Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRMAnn C Kroksveen, Elise Aasebø, Heidrun Vethe, et al.
Proteomics|February 4, 2016
Label-free analysis of human cerebrospinal fluid addressing various normalization strategies and revealing protein groups affected by multiple sclerosisJill A Opsahl, Marc Vaudel, Astrid Guldbrandsen, et al.
Proteomics|July 9, 2015
Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosisAnn C Kroksveen, Jacob D Jaffe, Elise Aasebø, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Analytical Chemistry|February 21, 2009
Discriminating variable test and selectivity ratio plot: quantitative tools for interpretation and variable (biomarker) selection in complex spectral or chromatographic profilesTarja Rajalahti, Reidar Arneberg, Ann C Kroksveen, et al.
Biochimica Et Biophysica Acta|December 21, 2014
Cerebrospinal fluid proteomics in multiple sclerosisAnn C Kroksveen, Jill A Opsahl, Astrid Guldbrandsen, et al.
Journal of Proteome Research|May 27, 2010
A multivariate approach to reveal biomarker signatures for disease classification: application to mass spectral profiles of cerebrospinal fluid from patients with multiple sclerosisTarja Rajalahti, Ann C Kroksveen, Reidar Arneberg, et al.
Cerebrospinal Fluid Research|June 12, 2010
Arachnoid cysts do not contain cerebrospinal fluid: A comparative chemical analysis of arachnoid cyst fluid and cerebrospinal fluid in adultsMagnus Berle, Knut G Wester, Rune J Ulvik, et al.
Proteomics. Clinical Applications|December 8, 2010
Pre-analytical influence on the low molecular weight cerebrospinal fluid proteomeFrode S Berven, Ann C Kroksveen, Magnus Berle, et al.
Analytical Chemistry|August 23, 2007
Pretreatment of mass spectral profiles: application to proteomic dataReidar Arneberg, Tarja Rajalahti, Kristian Flikka, et al.
Fluids and Barriers of the CNS|May 24, 2011
Protein profiling reveals inter-individual protein homogeneity of arachnoid cyst fluid and high qualitative similarity to cerebrospinal fluidMagnus Berle, Ann C Kroksveen, Oystein A Haaland, et al.
Journal of Proteomics|October 13, 2012
Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRMAnn C Kroksveen, Elise Aasebø, Heidrun Vethe, et al.
Proteomics|February 4, 2016
Label-free analysis of human cerebrospinal fluid addressing various normalization strategies and revealing protein groups affected by multiple sclerosisJill A Opsahl, Marc Vaudel, Astrid Guldbrandsen, et al.
Proteomics|July 9, 2015
Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosisAnn C Kroksveen, Jacob D Jaffe, Elise Aasebø, et al.
Pageof 2